Cargando…
Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19
The understanding of coronavirus disease 2019 (COVID-19) is evolving periodically. There is also a marked increase in COVID-19 patients’ demand for the provision of COVID-19 convalescent plasma (CCP) therapy. With the review of the literature, the stage of speculation is quickly moving towards confo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154358/ https://www.ncbi.nlm.nih.gov/pubmed/34054244 http://dx.doi.org/10.1055/s-0041-1727585 |
_version_ | 1783698995603832832 |
---|---|
author | Raturi, Manish Kala, Mansi Das, Kunal Kusum, Anuradha |
author_facet | Raturi, Manish Kala, Mansi Das, Kunal Kusum, Anuradha |
author_sort | Raturi, Manish |
collection | PubMed |
description | The understanding of coronavirus disease 2019 (COVID-19) is evolving periodically. There is also a marked increase in COVID-19 patients’ demand for the provision of COVID-19 convalescent plasma (CCP) therapy. With the review of the literature, the stage of speculation is quickly moving towards conformity, with the interim guidelines given by the Food and Drug Administration (FDA) in the United States, United Kingdom’s blood transfusion services, Saudi’s FDA, and the Indian Council for Medical Research, in addition to the European health authorities. It is prudent to address the ethical concerns that merit consideration while harvesting and utilizing CCP as a therapeutic tool in local hospital setting. |
format | Online Article Text |
id | pubmed-8154358 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81543582021-05-28 Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19 Raturi, Manish Kala, Mansi Das, Kunal Kusum, Anuradha J Lab Physicians The understanding of coronavirus disease 2019 (COVID-19) is evolving periodically. There is also a marked increase in COVID-19 patients’ demand for the provision of COVID-19 convalescent plasma (CCP) therapy. With the review of the literature, the stage of speculation is quickly moving towards conformity, with the interim guidelines given by the Food and Drug Administration (FDA) in the United States, United Kingdom’s blood transfusion services, Saudi’s FDA, and the Indian Council for Medical Research, in addition to the European health authorities. It is prudent to address the ethical concerns that merit consideration while harvesting and utilizing CCP as a therapeutic tool in local hospital setting. Thieme Medical and Scientific Publishers Pvt. Ltd. 2021-03 2021-04-24 /pmc/articles/PMC8154358/ /pubmed/34054244 http://dx.doi.org/10.1055/s-0041-1727585 Text en The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Raturi, Manish Kala, Mansi Das, Kunal Kusum, Anuradha Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19 |
title | Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19 |
title_full | Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19 |
title_fullStr | Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19 |
title_full_unstemmed | Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19 |
title_short | Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19 |
title_sort | reviewing the ethical concerns of the convalescent plasma therapy in covid-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154358/ https://www.ncbi.nlm.nih.gov/pubmed/34054244 http://dx.doi.org/10.1055/s-0041-1727585 |
work_keys_str_mv | AT raturimanish reviewingtheethicalconcernsoftheconvalescentplasmatherapyincovid19 AT kalamansi reviewingtheethicalconcernsoftheconvalescentplasmatherapyincovid19 AT daskunal reviewingtheethicalconcernsoftheconvalescentplasmatherapyincovid19 AT kusumanuradha reviewingtheethicalconcernsoftheconvalescentplasmatherapyincovid19 |